Multiple organ dysfunction syndrome
-
Upload
olubayode-akinbi -
Category
Health & Medicine
-
view
314 -
download
1
Transcript of Multiple organ dysfunction syndrome
MULTIPLE ORGAN DYSFUNCTION
SYNDROME BY
DR.AKINBI OLUBAYODE.O
INTRODUCTION Multiple organ dysfunction
syndrome (MODS), also known as multiple organ failure (MOF), total organ failure (TOF) or multisystem organ failure (MSOF)
MODS contributes to about 50% of ICU deaths
Failure of 2 to 3 organs is associated with 90% mortality.
Organ recovery is frequently the rule in surviving patients without pre-existing organ disease
DEFINITION: MODS is the presence of altered organ function in acutely ill patients such that homeostasis cannot be maintained without intervention. It usually involves two or more organ systems.SIRS is a systemic inflammatory response to a variety of insults including infection, ischemia, infarction, and injury, it leads to disorders of microcirculation, organ perfusion and finally secondary organ dysfunction.
HIGH RISK PATIENTS Patients with infection Shock episode associated with a rupture
aneurysm, acute pancreatitis, sepsis, burns or surgical operation.
Patients >65 years of age because of there decreased organ reserve and presence of co-morbidities
Severe trauma, multiple injury, massive blood loss, hypovolemic shock and infection.
ETIOLOGY Sepsis Major trauma Burns Pancreatitis Aspiration
syndromes Extracorporeal
circulation (e.g. cardiac bypass)
Multiple blood transfusion
Ischaemia–reperfusion injury
Autoimmune disease
Heat-induced illness
Eclampsia Poisoning/toxicity
CLASSIFICATION OF MODS1. Immediate type(primary):
Dysfunction/Failure occurring simultaneously in two or more organs due to primary disease.
2. Delayed type(secondary): Dysfunction occurred in one organ other organs sequentially fail.
3. Accumulation type: Dysfunction is cause by chronic disease. It is irreversible
PATHOGENESIS Organ dysfunction in a critically ill patient can be described in one of two ways: As the clinical intervention that was
employed to support the failing organ system (mechanical ventilation, hemodialysis, inotropic or vasopressor agents, parenteral nutrition etc), or
As the acute physiologic derangement that made such support necessary.
ORGAN SPECIFIC MANIFESTATION
GI dysfunction Hepatobiliary dysfunction Pulmonary dysfunction Renal dysfunction Cardiovascular dysfunction Coagulation system dysfunction others
GASTROINTESTINAL DYSFUNCTION
Gastrointestinal dysfunction in critical illness likely results from the interacting effects of reduced regional blood flow, impaired motility, and alterations in the normal microbial flora.
In the past, upper gastrointestinal bleeding or stress ulceration was the most common manifestation of gut dysfunction;
This complication has become uncommon with improvements in hemodynamic support, earlier diagnosis of infection, and the appropriate use of effective prophylaxis
Intolerance of enteral feeding, reflected in bloating and diarrhea is another manifestation of gut dysfunction.
However, in contrast to other organ systems, simple clinical measures of gut dysfunction are not readily available.
Gastrointestinal Dysfunction
Hypoperfusion Ischemia of the gut
Decreased integrity of the gut lining
Decreased peristalsis
Translocation of normal GI bacteria into systemic circulation
Colonization of normal GI flora up into the orpharynx
Systemic infection and SIRS
Aspiration of bacteria and initiation of a inflammatory response in the lung
HEPATOBILIARY DYSFUNCTION Hepatic dysfunction in MODS is reflected in
hyperbilirubinemia and cholestasis, rather than in biochemical evidence of hepatocellular injury or synthetic dysfunction.
A stereotypical pattern of altered hepatic protein synthesis - the acute phase response - typically accompanies MODS as a non-specific manifestation of systemic inflammation.
Serum levels of C reactive protein and alpha-1 anti-trypsin are elevated as part of the acute phase response, whereas levels of albumin, a negative acute phase reactant, are depressed.
Hepatobiliary Dysfunction
Hypoperfusion Ischemia of the liver and gallbladder
ischemic hepatitis acalculous cholecystitis
Jaundice
serum transaminase
serum bilirubin
Right upper pain and tenderness
Abdominal distention
Unexplained fever
Loss of bowel sounds
PULMONARY DYSFUNCTION The characteristic abnormality of the lung in
MODS is a failure of normal gas exchange, reflected predominantly in arterial hypoxemia.
Multiple pathologic factors contribute to impaired gas exchange.
Early in the course of lung injury, atelectasis and intravascular thrombosis or altered regional flow contribute to ventilation/perfusion mismatch, while increased capillary permeability leads to alveolar flooding and an increased diffusion distance for oxygen.
Regional injury resulting from infection or trauma contributes to compromised lung function.
With the institution of ventilatory support, lung injury can be aggravated through what has been termed volutrauma and barotrauma, leading to further atelectasis in dependent lung zones, and cyst formation in the anti-dependent zones.
Finally, the process of tissue repair, initiated with
the influx of inflammatory cells into the injured lung, results in fibrosis and hyaline membrane formation, the cardinal pathologic features of late ARDS.
RENAL DYSFUNCTION Renal dysfunction in MODS is reflected in
impairment of normal selective excretory function, initially in oliguria despite adequate intravascular volume, but later in a rising creatinine level, and fluid and electrolyte derangements of sufficient magnitude that dialysis is required.
Its causes are both pre-renal and renal. Reduced renal blood flow secondary to systemic hypotension, altered regional perfusion, or increased intra-abdominal pressure is an early risk factor;
Evolution of the disorder is compounded by pre-existing physiologic deficit and the effects of nephrotoxic drugs. Obstructive causes must be considered and ruled out.
As is the case for lung injury, ICU interventions contribute to the evolution of the syndrome: vasopressor agents cause further reductions in renal blood flow, while potentially nephrotoxic drugs are a key part of the anti-infective arsenal used in the ICU.
Renal Dysfunction
Hypoperfusion
And
Renal toxic drugs
Ischemia of the Kidney
Azotemia
Creatinine clearance
Fluid and electrolyte imbalances
Fluid volume overload
Renal Function
CARDIOVASCULAR DYSFUNCTION
The acute cardiovascular derangements of MODS consist of five features: A generalized reduction in peripheral vascular tone,
mediated largely through the local vasodilatory activity of nitric oxide
A generalized increase in capillary permeability producing diffuse capillary leak and edema, and contributing to further dysfunction in other organ systems
Alterations in regional blood flow to specific organ beds
Microvascular plugging and stasis, resulting from occlusion of the microvasculature by abnormally rigid erythrocytes and leukocytes, and resulting in arteriovenous shunting that contributes to a high mixed venous saturation
Myocardial depression, affecting the right side of the heart in particular
It is readily apparent that these abnormalities predispose to impaired oxygen delivery, and therefore contribute to the injury of other organ systems.
Cardiovascular Dysfunction
Initial response Myocardial
depression Right atrial pressure SVR Venous capacitance VO2 CO HR
Late response Ventricular dilatation Diastolic
compliance contractile
function CO Ability to maintain
BP without vasopressors
HEMATOLOGY DYSFUNCTION
Leucocytosis is an adaptive response to a variety of acute stresses and therefore commonly present, although not truly a manifestation of organ dysfunction.
Similarly a mild anemia resulting from both bone marrow suppression and iatrogenic blood-taking is common.
However the most widely cited manifestation of dysfunction of the hematologic system in MODS is thrombocytopenia, in its most extreme form resulting in disseminated intravascular coagulation (DIC).
Failure of the coagulation system is manifested as DIC.
Results in simultaneous microvascular clotting and hemorrhage in organ systems because of the depletion of clotting factors.
Like other manifestations of MODS, the causes of thrombocytopenia in critical illness are mainly - heparin-induced thrombocytopenia, intravascular consumption, and reduced production to name a few.
NEUROLOGIC DYSFUNCTION
An altered level of consciousness, reflected in a reduction in the Glasgow Coma Score, is the most readily recognizable manifestation of the neurologic dysfunction of MODS.
Its causes are multiple, including the iatrogenic effects of sedatives and analgesics, metabolic alterations, subclinical cerebral edema and reduced cerebral perfusion pressure, and, perhaps, micro-abscesses in the brain. A peripheral neuropathy - the so-called ‘critical illness polyneuropathy’ - is commonly present, though harder to measure.
Central Nervous System
Clinical Lab
Altered level of consciousnessImpaired mentationConfusionDeliriumPsychosis
Bispectral EEG monitoring
IMMUNOLOGIC DYSFUNCTION
Multiple abnormalities of non-specific and specific immune function are described in the critically ill patient, including impaired delayed type hypersensitivity responsiveness, altered production of antibodies, and a complex spectrum of abnormalities in the regulation of lymphocyte responses
The most readily evident, and clinically relevant manifestation of altered immunity in MODS is the development of nosocomial ICU-acquired infection, caused by relatively a virulent organisms.
The characteristic flora of ICU-acquired infection in MODS includes coagulase-negative Staphylococci,Enterococci, Candida, and Pseudomonas.
ENDOCRINE/METABOLIC DYSFUNCTION
Multiple metabolic and endocrine abnormalities are evident during MODS, although they are less well-characterized, Hyperglycemia and relative insulin resistance is both common and readily detected.
Less accessible abnormalities include the sick euthyroid syndrome, and relative adrenal insufficiency.
The latter has recently gained prominence as a promising therapeutic target for the patient with prolonged inflammation and organ dysfunction.
Metabolic/NutritionalClinical LabDecreased lean body massMuscle wastingSevere weight loss
Negative nitrogen balanceHyperglycemiaHypertriglyceridemiaIncreased serum lactateDecreased serum albumin,serum transferrin,prealbuminDecreased retinol-binding protein
MULTIPLE ORGAN DYSFUNCTION (MOD) SCORE
an system 0 1 2 3 4Respiratorya
(PO2/FIO2 Ratio)
> 300 226–300 151–225 76–150 ≤ 75
Renalb
(Serum Creatinine)
≤ 100 101–200 201–350 351–500 > 500
Hepaticc
(Serum Bilirubin)
≤ 20 21–60 61–120 121–240 > 240
Cardiovasculard
(R/P Ratio) ≤ 10.0 10.1–15.0 15.1–20.0 20.1–30.0 > 30.0Hematologice
(Platelet count)
> 120 81–120 51–80 21–50 ≤ 20
Neurologicf
(Glasgow Coma Score)
15 13–14 10–12 7–9 ≤ 6
Stage 1 the patient has increased volume requirements and mild respiratory alkalosis which is accompanied by oliguria, hyperglycemia and increased insulin requirements.
Stage 2 the patient is tachypneic, hypocapnic and hypoxemic; develops moderate liver dysfunction and possible hematologic abnormalities.
Stage 3 the patient develops shock with azotemia and acid-base disturbances; has significant coagulation abnormalities.
Stage 4 the patient is vasopressor dependent and oliguric or anuric; subsequently develops ischemic colitis and lactic acidosis.
The PO2/FIO2 ratio is calculated without reference to the use or mode of mechanical ventilation, and without reference to the use or level of PEEP.
The serum creatinine level is measured in μmol/liter, without reference to the use of dialysis.
The serum bilirubin level is measured in μmol/liter.
The R/P ratio is calculated as the product of the heart rate and right atrial (central venous) pressure, divided by the mean arterial pressure:
The platelet count is measured in platelets/mL 10-3
The Glasgow Coma Score is preferably calculated by the patient's nurse, and is scored conservatively (for the patient receiving sedation or muscle relaxants, normal function is assumed unless there is evidence of intrinsically altered mentation).
The relationship between MOD score and mortality of patient
MODS score mortality(%)0 0
9~12 2513~16 5017~20 75
>20 100
MANAGEMENT At present there is no agent that can reverse
the established organ failure. Therapy therefore is limited to prevention and supportive care
The principle are Decrease the severity of the risk factor Prevention of inflammation: drainage and
antibiotics Appropriate resuscitation and control of
infection Avoid unsuitable operation Treat the dysfunction organ and malnutrition
Correction of ischemia Interruption of pathological reaction:
hemofiltration Stabilization of internal environment:
water, electrolyte, acid base imbalance. Regulation of immunity: cellular and
humoral
The prevention of MODS in clinical illness
Target system Convincing evidence Controversial or investigational
Lung Pressure or volume limited ventilation to minimize barotrauma and volutrauma
Liquid ventilation, non-physiologic modes of ventilation (high frequency, oscillation)
Cardiovascular Restrict transfusion of packed red cells when hemoglobin is > 70
Supranormal oxygen delivery; non-crystalloid fluids; SwanGanz catheterization
Renal Avoidance of nephrotoxins
Continuous veno-venous hemofiltration
Gastrointestinal Stress ulcer prophylaxis with H2 blockers rather than sucralfate
Gastric tonometry
Enteral nutritionHematologic DVT prophylaxis Anticoagulant
therapies such as anti-thrombin III
Immunologic SDD (Selective Decontamination of the Digestive Tract)
Anti-cytokine and other mediator-targeted therapies (9)
Endocrine Corticosteroids in late sepsis
COMPLICATIONS Adult respiratory distress syndrome
(ARDS ) Disseminated Intravascular
Coagulation( DIC) Acute Renal failure (ARF) Intestinal bleeding Liver failure Central Nervous System dysfunction Heart failure Death
CONCLUSION Multiple organ failure is the commonest
cause of death in the intensive care unit setting.
There are numerous precipitating factors including sepsis, trauma and pancreatitis.
The resulting tissue hypoxia, exaggerated inflammatory response and generation of free oxygen radicals leads to tissue damage and organ dysfunction.
No definitive treatment exists despite considerable efforts to find a ‘magic bullet’.
Management still revolves around support of organ function and prevention of iatrogenic complications until recovery occurs.
An increasing emphasis is being placed on prevention of organ dysfunction, including maintenance of tissue oxygenation, nutrition and infection control.